Abstract:Introduction Negative symptoms (NS) are an important clinical characteristic of schizophrenia. In recent years, clinical research on NS has focused on their clinical heterogeneity. Based on two-factor analysis, it has been proposed to divide NS into abulia-apathy (AA) and expressive deficit (ED) domains. A number of studies have shown that these domains have different effects on the clinical features of schizophrenia, which suggests different pathophysiological mechanisms of their development. Neurobiological differences between AA and DE have been identified in neuroimaging and immunological studies but there is less research on the genetic background of NS. Objectives To search for an association between the rs1344706 polymorphism of the zinc finger protein gene (ZNF804A) and the AA and ED subdomains. The rs1344706 polymorphism is one of the best-supported risk variants for schizophrenia. The risk genotype AA has been shown to be associated with clinical presentations of the disease. Methods The study included 1116 (741 (66.3% women) patients with schizophrenia. The diagnosis was made according to ICD-10 criteria (item F20). The average age of the patients was 38.4 (13.6) years, age at disease onset was 26.1 (10.6) years. NS were assessed with the PANSS. The PANSS-derived AA domain consisted of Emotional withdrawal (PANSS item N2), Apathetic social withdrawal (N4), Active social avoidance (G16). The DE domain included Blunted affect (N1), Poor rapport (N3), Lack of spontaneity (N6), Mannerism and posturing (G5), Motor retardation (G7), Disturbance of volition (G13). Genotyping of the ZNF804A rs1344706 polymorphism was carried out using HRM-PCR. ANOVA with genotype and sex as independent variables, and age at the time of disease manifestation and its duration as covariates was used. Post hoc tests were performed using Bonferroni correction. Results A significant effect of the rs1344706 polymorphism on the severity of symptoms in the AA domain was revealed (F=5.88, df=2, p=0.002). In carriers of the CC genotype, the severity of symptoms was significantly lower than in carriers of the AA genotype and the AC genotype (8.4(3.5), 9.4(7.4) and 8.8(3.5) points, respectively). This effect was independent of sex and was not mediated by age at onset or duration of disease. There was no effect of the rs1344706 polymorphism on the severity of symptoms in the ED domain. Conclusions The association of the ZNF804A rs1344706 (A/C) polymorphism with NS of schizophrenia has not been reported so far though some studies have found the effect of this polymorphism on PANSS positive symptoms and PANSS total score. The finding of the association with NS can be explained by the fact that the NS heterogeneity was taken into account in the present study. Disclosure of Interest None Declared

Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample.

Significant Linkage and Association Between a Functional (gt)n Polymorphism in Promoter of the N-methyl-D-aspartate Receptor Subunit Gene (GRIN2A) and Schizophrenia.

A linkage study of N-Methyl-D-Aspartater receptor NR1 subunit gene and schizophrenia.

A Linkage Study of N-Methyl-D-aspartate Receptor 2A Subunit Gene and Schizophrenia

The PIP5K2A and RGS4 Genes Are Differentially Associated with Deficit and Non‐deficit Schizophrenia

Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition

A genome-wide association study of attention and executive function in patients with schizophrenia

Association of DTNBP1 with Schizophrenia: Findings from Two Independent Samples of Han Chinese Population

The genetics of schizophrenia: glutamate not dopamine?

Association Study of Neuregulin 1 Gene with Schizophrenia

A Two-Method Meta-Analysis of Neuregulin 1(NRG1) Association and Heterogeneity in Schizophrenia

Neuregulin-1 immunoreactivity in peripheral plasma is associated with rs6982890 polymorphism-mediated psychotic symptoms in schizophrenia

Identification and Functional Studies of Regulatory Variants Responsible for the Association of NRG3 with a Delusion Phenotype in Schizophrenia

Association Between NRGN Gene Polymorphism and Resting-State Hippocampal Functional Connectivity in Schizophrenia.

Genetic Association Between Nrg1 and Schizophrenia, Major Depressive Disorder, Bipolar Disorder in Han Chinese Population

Evaluation of a Susceptibility Gene for Schizophrenia: Genotype Based Meta-Analysis of RGS4 Polymorphisms from Thirteen Independent Samples.

Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia.

Association Study of Neuregulin 1 Gene Polymorphisms with Auditory P300 in Schizophrenia.

Polymorphisms in NRGN Are Associated with Schizophrenia, Major Depressive Disorder and Bipolar Disorder in the Han Chinese Population.

[Association Analysis of Neuregulin 1 Gene Polymorphism with Schizophrenia in Chinese Han Population].

The polymorphism ZNF804A rs1344706 is differentially associated with negative symptoms domains in schizophrenia